NFE2L2 and fatty liver disease: It was noted that the research work from Pi et al. [21] and Chartoumpekis et al. [38], which reported that Nrf2-null mice were somehow protected against HFD-induced obesity and fatty liver for long-term treatment (12 and 24 weeks, respectively).